NEWS COMMENTARY

Google invests $100 million in Amwell as the telehealth provider moves to Google Cloud services

Published:
August 28, 2020
Services:
Consumer
Activities:
Investment
by Danielle Bradnan
Very important

Google's role in healthcare analytics has been documented in digital therapeutics and through hospital systems like Ascension. It is now looking to telehealth as an additional pillar in its healthcare strategy by partnering with Amwell. Google is likely seeing Amwell as a strong player as one of the three biggest telehealth companies in the U.S., but it should be wary. In order to survive against competitors, Amwell will need a consumer-facing remote monitoring solution to compete with rival Teladoc, which just partnered with Livongo. With its recent cash influx from both Google and COVID-19 hype, clients can view Amwell as an opportune target for remote monitoring sales.

For the original news article, click here .


Further Reading

Personalized nutrition startup GenoPalate raises $4 million Series A round

News Commentary | January 04, 2021

GenoPalate intends to use the funding to double its customer capacity to at least 3,000 people daily. Sales growth for personalized nutrition startups appears to be flourishing, with multiple CEOs citing record sales in 2020 to Lux. GenoPalate could very well be on a similar trajectory. Moving into ... Not part of subscription

Teladoc leverages acquired Livongo ecosystem to strengthen mental health capabilities with myStrength Complete

News Commentary | May 18, 2021

When Teladoc acquired Livongo, it didn't just get a diabetes platform – it acquired an ecosystem of services around mental health, postnatal, and cardiovascular care. Teladoc will certainly be building out its capabilities in the coming months using the scaffolding that Livongo created, and it is ... To read more, click here.

Sensor manufacturer Rockley Photonics reveals Apple as key customer for wearable suite

News Commentary | June 02, 2021

The news comes from the company's public filing of a $1.2 billion SPAC deal, which it intends to use to raise funds for its full‑stack wearable sensor platform. Its sensor suite includes the capability to measure biomarkers like hydration, muscle lactate, and blood glucose. Measuring blood glucose ... Not part of subscription